These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

140 related articles for article (PubMed ID: 5927636)

  • 1. [Relations between urine excretion of hydroxyproline and alkaline serum phophatase in Paget's disease as expression of changes in collagen metabolism].
    Mühlbach R
    Beitr Orthop Traumatol; 1966 Apr; 13(4):189-96. PubMed ID: 5927636
    [No Abstract]   [Full Text] [Related]  

  • 2. [Hydroxyproline excretion in the urine in Paget's osteodystrophia deformans. Comparative clinical, morphological and biochemical studies].
    Raab W; Czitober H
    Wien Klin Wochenschr; 1967 Feb; 79(5):91-3. PubMed ID: 5591364
    [No Abstract]   [Full Text] [Related]  

  • 3. Biochemical markers of bone turnover in Paget's disease.
    Russell RG; Beard DJ; Cameron EC; Douglas DL; Forrest AR; Guilland-Cumming D; Paterson AD; Poser J; Preston CJ; Milford-Ward A; Woodhead S; Kanis JA
    Metab Bone Dis Relat Res; 1981; 3(4-5):255-62. PubMed ID: 6220191
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Chromatographic analysis of urinary amino acids in Paget's disease. I : Biochemical study. Isolation and amino acid composition of a urinary peptide specific to this bone disease].
    Fabier JL; Viau M; Constans J; Clerc A
    Rev Rhum Mal Osteoartic; 1976 Apr; 43(4):249-53. PubMed ID: 1273474
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Bone mineral measurement in Paget's disease].
    Nuti R; Vattimo A
    Boll Soc Ital Biol Sper; 1978 Jan; 54(2):141-5. PubMed ID: 737061
    [No Abstract]   [Full Text] [Related]  

  • 6. [Biological exploration of Paget's disease (author's transl)].
    Nagant de Deuxchaisnes C; Rombouts-Lindemans C
    J Belge Rhumatol Med Phys; 1974; 29(5-6):243-92. PubMed ID: 4470109
    [No Abstract]   [Full Text] [Related]  

  • 7. Effects of calcitonin in Paget's disease and polyostotic fibrous dysplasia.
    Bell NH; Avery S; Johnston CC
    J Clin Endocrinol Metab; 1970 Sep; 31(3):283-90. PubMed ID: 4916538
    [No Abstract]   [Full Text] [Related]  

  • 8. Treatment of Paget's bone disease with the bisphosphonate APD.
    Mautalen CA
    Henry Ford Hosp Med J; 1983; 31(4):244-8. PubMed ID: 6425243
    [No Abstract]   [Full Text] [Related]  

  • 9. [How to determine Paget's disease activity and which patients to treat?].
    Renier JC
    Presse Med; 1984 May; 13(20):1276-7. PubMed ID: 6232591
    [No Abstract]   [Full Text] [Related]  

  • 10. Measurement of skeletal blood flow in normal man and in patients with Paget's disease of bone.
    Wootton R; Reeve J; Veall N
    Calcif Tissue Res; 1976 Aug; 21 Suppl():380-5. PubMed ID: 782666
    [No Abstract]   [Full Text] [Related]  

  • 11. [Biological and isotope explorations in Paget's disease of bone].
    Dell'Anno R; Eisinger J; Recordier AM
    Rhumatologie; 1971 Apr; 23(4):119-39. PubMed ID: 4254981
    [No Abstract]   [Full Text] [Related]  

  • 12. [The value of the calcitonin test in Paget's disease of bone].
    D'Amore M; Bozzi A; Telesca ML; Carrozzo M
    Minerva Med; 1981 Apr; 72(14):865-8. PubMed ID: 7219796
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Paget's disease of the proximal ulna--a rare monostotic manifestation].
    Klepsch M; Seidel T; Runkel M
    Z Orthop Ihre Grenzgeb; 1997; 135(3):258-60. PubMed ID: 9334082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Use of biochemical markers of bone turnover in Paget's disease of bone].
    Vignot E; Meunier PJ
    Ann Biol Clin (Paris); 2001; 59(3):309-11. PubMed ID: 11397680
    [No Abstract]   [Full Text] [Related]  

  • 15. [The treatment of Paget's disease of bone with second-generation bisphosphonates via intravenous infusion].
    Arboleya L; Sánchez J; Iglesias G; Arranz JL
    Rev Clin Esp; 1993 Dec; 193(9):467-71. PubMed ID: 8108576
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Studies of variations in several biological parameters in Paget's disease (phosphatases, hydroxyproline...) before and after treatment with aspirin].
    Galmiche P; Lévy P
    Rev Rhum Mal Osteoartic; 1967 Apr; 34(4):185-92. PubMed ID: 6059924
    [No Abstract]   [Full Text] [Related]  

  • 17. Measurement of urinary excretion of nonisomerized and beta-isomerized forms of type I collagen breakdown products to monitor the effects of the bisphosphonate zoledronate in Paget's disease.
    Garnero P; Gineyts E; Schaffer AV; Seaman J; Delmas PD
    Arthritis Rheum; 1998 Feb; 41(2):354-60. PubMed ID: 9485094
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of magnesium metabolism and the effects of fluoride therapy in Paget's disease of bone.
    Avioli LV; Berman M
    J Clin Endocrinol Metab; 1968 May; 28(5):700-10. PubMed ID: 5653203
    [No Abstract]   [Full Text] [Related]  

  • 19. Sustained biochemical effects of short treatment of Paget's disease of bone with dichloromethylene diphosphonate.
    Chapuy MC; Charhon SA; Meunier PJ
    Metab Bone Dis Relat Res; 1983; 4(6):325-8. PubMed ID: 6229683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Comparative studies of the behavior of blood calcium and urinary hydroxyproline after infusion of calcitonin and glucagon in patients with Paget's disease].
    Lo Cascio V; Lechi C; Adami S; Bianchi I; Cominacini L; Galvanini G
    Boll Soc Ital Biol Sper; 1974 Jan; 50(1-2):55-61. PubMed ID: 4425587
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.